H.U. Group Holdings Inc
TSE:4544

Watchlist Manager
H.U. Group Holdings Inc Logo
H.U. Group Holdings Inc
TSE:4544
Watchlist
Price: 2 429 JPY -1.82% Market Closed
Market Cap: 138B JPY
Have any thoughts about
H.U. Group Holdings Inc?
Write Note

H.U. Group Holdings Inc
Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

H.U. Group Holdings Inc
Long-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
H.U. Group Holdings Inc
TSE:4544
Long-Term Debt
ÂĄ60.1B
CAGR 3-Years
3%
CAGR 5-Years
16%
CAGR 10-Years
14%
Solasto Corp
TSE:6197
Long-Term Debt
ÂĄ17.6B
CAGR 3-Years
18%
CAGR 5-Years
18%
CAGR 10-Years
N/A
BML Inc
TSE:4694
Long-Term Debt
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
V
Value HR Co Ltd
TSE:6078
Long-Term Debt
ÂĄ5.1B
CAGR 3-Years
-8%
CAGR 5-Years
-2%
CAGR 10-Years
15%
France Bed Holdings Co Ltd
TSE:7840
Long-Term Debt
ÂĄ11.3B
CAGR 3-Years
68%
CAGR 5-Years
24%
CAGR 10-Years
12%
C
CUC Inc
TSE:9158
Long-Term Debt
ÂĄ23.6B
CAGR 3-Years
85%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

H.U. Group Holdings Inc
Glance View

Market Cap
138B JPY
Industry
Health Care

H.U.Group Holdings, Inc. provides the strategic planning, investor relations, public relations, and supervisory management of the entire group. The company is headquartered in Shinjuku, Tokyo-To and currently employs 5,897 full-time employees. Group Holdings Inc, formerly Miraca Holdings Inc is a Japan-based holding company engaged in manufacture and sale of clinical test drugs, entrusted clinical examination and sterilization related business. The firm operates in four business segments. The Outsourced Clinical Testing segment accepts special tests from medical institutions. The Clinical Laboratory Medicine segment manufactures and sells clinical laboratory medicines and sells them to medical institutions and contract clinical laboratory companies. The Sterilization segment mainly entrusts the sterilization of medical equipment used for medical treatment in hospitals of large-scale hospitals and the related operations. The New Development & Others segment is involved in the homecare & welfare equipment business, self-medication & health insurance business, food & environment & cosmetics inspection business.

Intrinsic Value
5 047.42 JPY
Undervaluation 52%
Intrinsic Value
Price

See Also

What is H.U. Group Holdings Inc's Long-Term Debt?
Long-Term Debt
60.1B JPY

Based on the financial report for Sep 30, 2024, H.U. Group Holdings Inc's Long-Term Debt amounts to 60.1B JPY.

What is H.U. Group Holdings Inc's Long-Term Debt growth rate?
Long-Term Debt CAGR 10Y
14%

Over the last year, the Long-Term Debt growth was -6%. The average annual Long-Term Debt growth rates for H.U. Group Holdings Inc have been 3% over the past three years , 16% over the past five years , and 14% over the past ten years .

Back to Top